Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v9-FR
Language French French
Date Updated 2018-07-24 2018-05-31
Drug Identification Number 02391457 02391457
Brand name CIPRALEX MELTZ CIPRALEX MELTZ
Common or Proper name Escitalopram Escitalopram
Company Name LUNDBECK CANADA INC LUNDBECK CANADA INC
Ingredients ESCITALOPRAM ESCITALOPRAM
Strength(s) 20MG 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-06-15 2018-06-15
Actual discontinuation date 2018-06-15
Remaining supply date 2018-06-15 2018-06-15
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments